Major adverse cardiac events (MACEs)
Showing 1 - 25 of >10,000
![](/image/sponsor/university_of_campania_"luigi_vanvitelli")
GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Myocardial Infarction
- PCI
-
Naples, ItalyCelestino Sardu
Aug 31, 2023
Cardiovascular Diseases Trial in Peking (cardiovascular magnetic resonance (CMR))
Completed
- Cardiovascular Diseases
- cardiovascular magnetic resonance (CMR)
-
Peking, Beijing, ChinaChinese PLA General Hospital
Apr 3, 2022
Diabetes, Type 2, Major Adverse Cardiac Events Trial in Hangzhou (CGM)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Major Adverse Cardiac Events
- CGM
-
Hangzhou, Chinathe Second Affiliated Hospital Zhejiang University Schoolof Medi
Sep 23, 2023
Noncardiac Surgery Trial in Guangzhou (Perioperative cardiac biomarker measurement)
Recruiting
- Noncardiac Surgery
- Perioperative cardiac biomarker measurement
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 2, 2023
Risk Factors for Predictors of MACEs After RA-CABG
Completed
- Coronary Artery Disease
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
Nov 30, 2021
Inclisiran on Major Adverse Cardiovascular Events in French
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Inclisiran sodium
- +3 more
- (no location specified)
Jul 26, 2023
Cardiovascular Primary Prevention Strategy Trial in Murray (Coronary Artery Calcium Screening and Statin Treatment, Standard
Recruiting
- Cardiovascular Primary Prevention Strategy
- Coronary Artery Calcium Screening and Statin Treatment
- Standard Treatment
-
Murray, UtahIntermountain Medical Center and Intermountain Clinics
Aug 8, 2022
Cardiac Tumor and Risk Stratification of Subsequent Adverse
Not yet recruiting
- Cardiac Tumor
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiantong University
Oct 19, 2023
Novel Cardiovascular Biomarkers in Patients With Kidney Disease
Not yet recruiting
- Haemodialysis Complication
- Major Adverse Cardiac Events
- Cardiac Biomarkers
- +2 more
- (no location specified)
Sep 14, 2023
Cardiac Disease Trial in San Donato Milanese (Cerebral autoregulation monitoring)
Not yet recruiting
- Cardiac Disease
- Cerebral autoregulation monitoring
-
San Donato Milanese, Milan, ItalyVlasta Bari
Mar 15, 2023
Adverse Events in Acute Limb Ischemic Patient Undergoing
Recruiting
- Major Adverse Cardiac Events
- Adverse Effect of Unspecified General Anesthetic
-
Bangkok, Thailand
- +1 more
May 3, 2022
Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)
Not yet recruiting
- Obesity
- Naltrexone-Bupropion (NB) Combination
- Placebo
- (no location specified)
Oct 18, 2023
Anticoagulant Drug Intervention on Postoperative MALE and MACE
Recruiting
- Anticoagulant Drugs
- +2 more
- anticoagulant or antiplatelet drugs
-
Hangzhou, None Selected, ChinaFirst Affiliated Hospital of Zhejiang University
May 8, 2023
Major Adverse Cardiovascular Events in Coronary Artery Disease
Completed
- Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
-
Jinan, Shandong, ChinaYuguo Chen
Sep 20, 2022
Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke Trial (low-dose rivaroxaban, Standard-dose rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- +3 more
- low-dose rivaroxaban
- Standard-dose rivaroxaban
- (no location specified)
Oct 25, 2023
Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)
Not yet recruiting
- Arteriosclerosis
- Hypercholesterolaemia
- MK-0616
- Placebo
- (no location specified)
Aug 17, 2023
Acute Kidney Injury, Septic Shock, Nicotinamide Trial in Amiens (Nicotinamide treatment, treatment)
Recruiting
- Acute Kidney Injury
- +3 more
- Nicotinamide treatment
- placebo treatment
-
Amiens, FranceCHU Amiens
Dec 8, 2022
Coronary Artery Disease Trial in United States (Colchicine, Placebo)
Not yet recruiting
- Coronary Artery Disease
- Colchicine
- Placebo
-
Long Beach, California
- +4 more
Nov 15, 2022
Endothelial Dysfunction and Non-cardiac Surgery
Recruiting
- Surgery
- +3 more
- FMD - Troponin measurement
-
Independencia, Santiago, ChileHospital Clínico de la Universidad de Chile
Mar 25, 2023
Adverse Events in Pediatric Cardiac Surgery
Completed
- Congenital Heart Disease in Children
- +2 more
- Fluid balance
-
Brussels, BelgiumHôpital Universitaire des Enfants Reine Fabiola
Jul 19, 2022
Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)
Not yet recruiting
- Primary Prevention of Atherosclerotic Cardiovascular Disease
- Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
- Placebo in 1.5ml
- (no location specified)
Feb 13, 2023
CT-based Myocardial Characterization (CTMyoC)
Recruiting
- Different Cardiomyopathy and Major Cardiovascular Adverse Events
-
Milano, ItalyIRCCS San Raffaele
Sep 1, 2023
Washington Hospital Center With Drug Eluting Stents - Synergy
Active, not recruiting
- Incidence of Major Adverse Cardiac Events
- PCI with Synergy Stent
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Jan 3, 2022
Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)
Not yet recruiting
- Coronary Artery Disease Progression
- Intensive lipid-lowering control
- Moderate-intensity lipid-lowering control
- (no location specified)
Jul 13, 2022
Major Adverse Cardiovascular Events for Naldemedine and Other
Recruiting
- Opioid-induced Constipation
- Naldemedine
- +2 more
-
Wilmington, DelawareResearch Site
Feb 28, 2022